79 related articles for article (PubMed ID: 7028259)
1. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.
Lad TE; Nelson RB; Diekamp U; Kukla LJ; Sarma PR; Larson CS; Currie ET; Chawla MS; Tichler T; Zawila P; McGuire WP
Cancer Treat Rep; 1981; 65(11-12):973-8. PubMed ID: 7028259
[TBL] [Abstract][Full Text] [Related]
2. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
[TBL] [Abstract][Full Text] [Related]
3. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
Ruckdeschel JC; Mehta CR; Salazar OM; Creech RH; Sponzo RW
Cancer Treat Rep; 1981; 65(11-12):959-63. PubMed ID: 6794909
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
7. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Rambotti P; Park YK
Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
9. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
Perevodchikova NI; Bychkov MB; Ausekar BV
Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
11. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
12. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
Knost JA; Greco FA; Hande KR; Richardson RL; Fer MF; Oldham RK
Cancer Treat Rep; 1981; 65(11-12):941-5. PubMed ID: 7028255
[TBL] [Abstract][Full Text] [Related]
13. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
Xu G; Rong T; Lin P
Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
[TBL] [Abstract][Full Text] [Related]
15. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
Lilenbaum RC; List M; Desch C
Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
[TBL] [Abstract][Full Text] [Related]
16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
17. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
[TBL] [Abstract][Full Text] [Related]
18. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Miller CF; Weltz MD; Heim WJ; Blom J
Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
[No Abstract] [Full Text] [Related]
19. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
Słowik-Gabryelska A; Szczepanik A; Kalicka A
Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
[TBL] [Abstract][Full Text] [Related]
20. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
